FRIDAY, May 16, 2025 (HealthDay News) — Low-income Medicare beneficiaries are more likely to die if they lose access to crucial medication coverage, a new study says. More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces their drug costs, researchers saidContinue Reading
THURSDAY, May 15, 2025 (HealthDay News) — President Donald Trump’s choice for U.S. surgeon general has raised eyebrows for promoting the use of psychedelic drugs, such as psilocybin, in a 2024 book and her personal newsletter. His choice for the post is wellness influencer Dr. Casey Means, who was recommendedContinue Reading
THURSDAY, May 15, 2025 (HealthDay News) — The 2023 approval of the first drug shown to slow the progression of Alzheimer’s disease came with no small amount of concern from skeptics. Lecanemab (Leqembi) modestly slows Alzheimer’s by helping the body flush out amyloid beta proteins associated with toxic plaques in theContinue Reading
WEDNESDAY, May 14, 2025 (HealthDay News) — Exercise and sports appear to help kids avoid mental health problems as they grow into young adults, a new study says. Young children who participated in sports teams and physical education classes were less likely to develop problems like depression, anxiety and addictionContinue Reading
TUESDAY, May 13, 2025 (HealthDay News) — Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says. Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading inside a person’s body. Now, aContinue Reading
MONDAY, May 12, 2025 (HealthDay News) — More Americans use illicit opioids like fentanyl than previously estimated, undercutting perceived progress in confronting the U.S. opioid crisis, a new study says. More than 1 in 10 American adults (11%) reported illicit opioid use within the past 12 months, researchers reported MayContinue Reading
FRIDAY, May 9, 2025 (HealthDay News) — More talk and fewer pills are being employed to help Americans maintain their mental health, a new study says. Psychotherapy is assuming a larger role in mental health care, while medications prescribed without accompanying therapy are becoming less common, according to results publishedContinue Reading
THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug Administration (FDA) says it wants more data before it can be approved. Moderna researchers reported that the combo shot produced a strongerContinue Reading
THURSDAY, May 8, 2025 (HealthDay News) — A new drug combo lowers “bad” LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing one, ezetimibe. In a Phase 3 clinical trial, this combo reduced LDL levelsContinue Reading
WEDNESDAY, May 7, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research. The division oversees vaccines and biologic medicines, including gene therapies, CNN reported. Prasad isContinue Reading